VeriMomci 77891 est-il sûr pendant la grossesse ?
Titanium dioxide (CI 77891, CAS 13463-67-7) has no harmonised reproductive classification and key cosmetic safety bodies (CIR, SCCS opinions) have not identified reproductive toxicity for dermal cosmetic use; aggregated GHS entries (e.g., PubChem GHS) list several hazards (irritation, inhalation carcinogen H351) but these do not include a harmonised reproductive hazard (no H360/H361 harmonised classification). Dermal absorption is negligible in cosmetic use, so reproductive hazard via topical exposure is not supported.
Pregnancy-safe products containing ci 77891
Related ingredients
Frequently asked questions
- ci 77891 est-il sûr pendant la grossesse ?
- Titanium dioxide (CI 77891, CAS 13463-67-7) has no harmonised reproductive classification and key cosmetic safety bodies (CIR, SCCS opinions) have not identified reproductive toxicity for dermal cosmetic use; aggregated GHS entries (e.g., PubChem GHS) list several hazards (irritation, inhalation carcinogen H351) but these do not include a harmonised reproductive hazard (no H360/H361 harmonised classification). Dermal absorption is negligible in cosmetic use, so reproductive hazard via topical exposure is not supported.
- ci 77891 est-il sûr pendant l'allaitement ?
- Same rationale as pregnancy: no credible evidence of reproductive or lactation-specific toxicity from cosmetic topical use. Titanium dioxide is insoluble and not systemically bioavailable from intact skin in typical formulations; regulatory safety assessments (CIR, SCCS) support safety for topical use, aside from inhalation risks for powders.
- ci 77891 est-il sûr pour la peau de bébé ?
- Hazard and mechanism: no infant-specific reproductive or mechanistic concerns documented. Exposure: adult dermal absorption is negligible, but infant skin has higher permeability and higher surface-area-to-weight, so exposure score is increased by +1 per the requested rule. Regulatory assessments still do not identify intrinsic reproductive or developmental risks from topical CI 77891, but data on nanoparticulate forms and very young infants are more limited.
- Comment VeriMom évalue-t-il ci 77891 ?
- VeriMom évalue ci 77891 à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à ci 77891 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à ci 77891 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.